ReviewJournal of Korean medical science2022
COVID-19 Vaccination in Korea: Past, Present, and the Way Forward.
Review in Journal of Korean medical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 40 citations in OpenAlex.
- COVID-19 Vaccination Strategy and Evidence in Korea.Journal of Korean medical science · 2026Review
- Pediatric COVID-19 in Korea: Lessons and Strategies for Future Disease-X Preparedness.Journal of Korean medical science · 2026Review
- COVID-19 legislative response and challenges in Republic of Korea.Frontiers in public health · 2026Review
- Immunogenicity and Breakthrough Outcomes of mRNA Booster Strategies Among Healthcare Workers During the BA.1/BA.2 Omicron Surge.Microorganisms · 2025Article
- Public Health Insights from Social Media Analysis during the COVID-19 Pandemic in South Korea.Iranian journal of public health · 2025Article
- Seroprevalence Trends of Antibodies to SARS-CoV-2 in South Korea, 2021-2022: A Repeated Cross-Sectional Study.Influenza and other respiratory viruses · 2025Article
- Changes in the Nationwide Incidence of Bell's Palsy in the General Population Before and After the COVID-19 Pandemic: An Ecological Study.Journal of medical virology · 2025Article
- Coronavirus disease-2019 (COVID-19) outbreak in a long-term care hospital in Korea in early 2021.Infection prevention in practice · 2025Article
- Comparison of the efficacy of COVID-19 responses in South Korea and the United States.Global health action · 2024Article
- Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021-2022.Emerging infectious diseases · 2024Article
- Preoperative COVID-19 and Postoperative Mortality in Cancer Surgery: A South Korean Nationwide Study.Annals of surgical oncology · 2024Article
- Cardiovascular Safety of COVID-19 Vaccination in Patients With Cancer: A Self-Controlled Case Series Study in Korea.Journal of Korean medical science · 2024Article
- The Impact of the COVID-19 Pandemic on Bell's Palsy and Ramsay-Hunt Syndrome: A Multicenter Retrospective Study.Journal of Korean medical science · 2024Article
- Correlation of geopolitics, education, democracy with COVID-19 vaccination rate.BMC public health · 2024Article
- Magnitude and Duration of Serum Neutralizing Antibody Titers Induced by a Third mRNA COVID-19 Vaccination against Omicron BA.1 in Older Individuals.Infection & chemotherapy · 2024Article
- Pneumonia Prevalence Upon Chest Radiography According to Vaccination Status Among Patients Under 50 Years of Age With Coronavirus Disease 2019.Journal of Korean medical science · 2024Article
- Establishment of Safety Monitoring System for Vaccines Not Included in the National Immunization Program in Korea.Journal of Korean medical science · 2024Article
- Mortality Rate and Outcomes of Omicron Variant Positive Patients with Osteoporotic Fractures: A Retrospective Study.Journal of bone metabolism · 2024Article
- Trends in Research on Patients With COVID-19 in Korean Medical Journals.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2024Article
- Factors Associated with Treatment Satisfaction in Korean Patients with Psoriasis.Patient preference and adherence · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since its first emergence in late 2019, severe acute respiratory syndrome coronavirus-2 has claimed more than 6.5 million lives worldwide and continues to infect hundreds of thousands of people daily. To combat this once-in-a-century disaster, several vaccines have been developed at unprecedented speeds. Novel vaccine platforms (messenger ribonucleic acid vaccines and adenoviral vector vaccines) have played a major role in the current pandemic. In Korea, six vaccines, including a domestically developed recombinant vaccine, have been approved. As in other countries, vaccines have been proven to be safe and highly effective in Korea. However, rare serious adverse events and breakthrough infections have undermined public trust in the vaccines, even while the benefits of vaccination far outweigh the risks. The rise of the omicron variant and the subsequent increase in excess mortality demonstrated that while vaccines are a key component of the pandemic response, it alone can fail without non-pharmaceutical interventions like masking and social distancing. The pandemic of coronavirus disease has revealed both the strengths and weaknesses of our healthcare system and pandemic preparedness. When the next pandemic arrives, improved risk communication and vaccine development should be prioritized. To enable timely vaccine development, it is essential to make strategic and sufficient investments in vaccine research and development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.